Lexeo Therapeutics (LXEO) Non Operating Income (2022 - 2026)
Lexeo Therapeutics (LXEO) reported Non Operating Income of $2.15 million for Q2 2026, down 53.0% from $4.59 million a year earlier but up 0.7% from the prior quarter.
Powered by 
Analysis
Lexeo Therapeutics (LXEO) Non Operating Income (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Lexeo Therapeutics' Non Operating Income came in at $7.85 million, down 15.1% year-over-year; for FY2025, it was $9.3 million, up 25.1% from FY2024.
- Non Operating Income has increased for three consecutive years, with a three-year compound annual growth rate of 96.1% (FY2022 to FY2025).
- By year, Non Operating Income came in at $7.43 million in FY2024 (+250.8%), $2.12 million in FY2023 (+72.0%) and $1.23 million in FY2022.
- Five-year quarterly Non Operating Income spans a low of $165,000 in Q3 2023 and a high of $4.59 million in Q2 2025.
- Year over year, Non Operating Income gained in four of the last seven quarters, with growth averaging 29.3%.
- The high point for year-over-year Non Operating Income in five years was Q2 2024 (growth of 333.0%); the low point was Q3 2023 (a decline of 61.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.14 million (Q1 2026), $2.2 million (Q4 2025) and $1.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Lexeo Therapeutics | 240.59 Mn | -419.82 Mn | - | 2.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.15 Mn |
| Mar 31, 2026 | 2.14 Mn |
| Dec 31, 2025 | 2.20 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 4.59 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 2.05 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Dec 31, 2023 | 787,000.00 |
| Sep 30, 2023 | 165,000.00 |
| Jun 30, 2023 | 534,000.00 |
| Mar 31, 2023 | 633,000.00 |
| Dec 31, 2022 | 620,000.00 |
| Sep 30, 2022 | 427,000.00 |
API Access
Lexeo Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=LXEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "LXEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=LXEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();